The main benefits of GLP-1 therapy include: Enhanced insulin secretion in response to meals Reduced glucagon release, preventing high blood sugar levels Slowed gastric emptying, leading to prolonged satiety Decreased appetite, which may help with weight loss Currently available GLP-1 receptor agonists include drugs like liraglutide (Victoza), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
For the purpose of anti-aging therapy (with no surgical adjunct), I typically place patients on one IV infusion monthly, maybe a few times the first month, and then encourage subcutaneous doses weekly or every two weeks in between
Further in vitro analysis revealed GHK-Cus capacity to attenuate the release of key pro-inflammatory cytokines
Flag any bothersome symptoms or health concerns to your clinician to find treatments that help you feel like yourself again
Results Here, in normal rats, after tail amputation (spontaneous bleeding for 20 minutes, fall in platelet count without any failure of coagulation parameters) the previous effects of BPC 157 (reduced bleeding, no thrombocytopenia) [15] were confronted with that of L-arginine (prolonged bleeding without thrombocytopenia) and L-NAME (reduced bleeding, thrombocytopenia present), given alone and/or combined
But this route has not been yet approved by FDA